Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > Type 1 Discovery magazine – free copy
Thanks to the generosity of supporters, scientific breakthroughs are transforming what it means to live with type 1 diabetes (T1D). Our latest edition is filled with inspiring stories and exciting developments.
Inside you’ll discover:
Read the digital version of the magazine on Issuu. Alternatively you can download it as a PDF.
If you have a story to share for Type 1 Discovery, email us at info@breakthrought1d.org.uk.
Sign up using the form below and receive your first free copy of Type 1 Discovery soon!
We’d love to keep you updated on how your support is helping to cure, treat and prevent type 1 diabetes. We will send you information about our work, events, ways to get involved and fundraising. Simply let us know how you’d like to hear from us.
We respect your privacy. We will never share your information with any third party. For full details see our privacy policy.
We are delighted with the decision to approve teplizumab for use on the NHS.
We look at a new feature coming to the CamAPS FX app, which will allow users to remove the need to count carbohydrates before a meal.
New data presented this week at the American Diabetes Association’s (ADA) 86th Scientific Sessions shows incredible promise: all 12 participants in the Eledon trial, testing the immunosuppressive drug tegoprubart, are no longer injecting insulin.
In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.
Would you like to visit the website of our {{ affiliate_country }} affiliate to complete your action?
